EnteroMedics Inc.
ETRM
ETRM was delisted on the 20th of October, 2017.
16 hedge funds and large institutions have $646K invested in EnteroMedics Inc. in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 11 closing their positions.
4,900% more call options, than puts
Call options by funds: $50K | Put options by funds: $1K
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
38% less funds holding
Funds holding: 26 → 16 (-10)
44% less capital invested
Capital invested by funds: $1.14M → $646K (-$498K)
91% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$87.2K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$65.7K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$48.4K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.48K |
| 5 |
FANJ
Financial Architects (New Jersey)
Marlton,
New Jersey
|
+$2.23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$225K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$75K |
| 3 |
EPM
Equitec Proprietary Markets
Chicago,
Illinois
|
-$74K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$64K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$59K |
ETRM Hedge Fund Activity: Q2 2017 in Review
16 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q2 2017, worth a combined $646K — down 44% from $1.14M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ETRM and 1 opened new positions — a net loss of 10 holders — while 4 trimmed existing stakes and 6 added.
The largest buyer was BlackRock, adding an estimated $87.2K. The largest seller was Morgan Stanley, cutting an estimated $225K.
- 16 institutional investors held EnteroMedics Inc. (ETRM) as of Q2 2017, down from 26 in Q1 2017.
- Funds reported $646K of EnteroMedics Inc. stock for Q2 2017, down 44% quarter-over-quarter.
- 1 fund opened new EnteroMedics Inc. positions in Q2 2017 and 11 closed out, a net change of -10 holders.
- The largest EnteroMedics Inc. buyer in Q2 2017 was BlackRock, an estimated $87.2K added.
- The largest EnteroMedics Inc. seller in Q2 2017 was Morgan Stanley, an estimated $225K sold.
Based on aggregated 13F filings for Q2 2017.